| | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | Three Months Ended June 30, | | Six Months Ended June 30, |
| Financial statement caption | | 2025 | | 2024 | | 2025 | | 2024 |
| Non-Designated Derivative Instruments | | | | | | | | | |
| | | | | | | | | |
| | | | | | | | | |
| | | | | | | | | |
| | | | | | | | | |
| Unrealized (gains) losses | Other (income) expense, net | | $ | — | | | $ | 1 | | | $ | (2) | | | $ | 47 | |
| Designated Derivative Instruments | | | | | | | | | |
| Realized (gains) losses | Interest and debt (income) expense | | $ | (7,883) | | | $ | (14,433) | | | $ | (16,078) | | | $ | (28,978) | |
| Unrealized (gains) losses | Comprehensive (income) loss | | $ | 9,107 | | | $ | (14,021) | | | $ | 25,216 | | | $ | (51,711) | |
| | | | | | | | | |
| | | | | | | | | |